Australia's Optiscan rises after imaging more than 80 cases in ACL study
10/09/2026 02:40
BUZZ-Australia's Optiscan rises after imaging more than 80 cases in ACL study ** Shares of Australia's Optiscan Imaging OIL.AX rise as much as 10% to A$0.165, their biggest intraday pct gain since August 19
** Shares hit their highest levels since August 27
** The medical technology firm says it has imaged more than 80 cases in a study with Australian Clinical Labs (ACL) using its InForm digital pathology imaging device
** Company says study uses InForm device for real-time, slide-free cellular imaging at point of contact, in real-world pathology environment
** Optiscan stock up 60%, YTD
(Reporting by Subhalakshmi Dey in Bengaluru)
Recent news on Optiscan Imaging
See all newsAustralia's Optiscan rises after FDA filing for surgery imaging device
Brief: Optiscan Imaging Lodges US FDA 510(K) Submission For Inform Digital Pathology Device
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australia's Optiscan Imaging gains on signing new cross-border research deal
Brief: Optiscan Imaging Lodges US FDA Dossier For Inspecta For Veterinary Market